Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

HitGen and Viva Biotech Team Up to Provide Early-Stage CRO Services

publication date: Dec 24, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
HitGen Ltd. and Viva Biotech Ltd., two China CROs specializing in early-stage services, announced a new collaboration. HitGen, located in Chengdu, offers lead generation services. VivaBiotech of Shanghai is a structure-based drug discovery CRO. According to the two companies, their now-integrated early hit-to lead generation program addresses a previously unmet need in China’s pre-clinical drug discovery sector. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors